Let’s get analytical: Molecular Health leverage RWD for adverse drug reactions

Researchers from Molecular Health (Heidelberg, Germany) and the University of Florida (FL, USA) have collaborated to improve the field’s understanding of adverse drug effects and reactions. The team utilized past real-world data (RWD) databases to hypothesize about why patients could react to a treatment. The first study, involving individuals from Molecular Health and the University of Florida investigated real-world evidence (RWE) from cardiotoxicity reports from patients prescribed trastuzumab, combined with four additional medications. Trastuzumab is used in the treatment of breast cancer and stomach cancer, by attacking HER2 proteins. When comparing the RWE obtained from the cardiotoxicity reports to research...